Skip to main navigation Skip to search Skip to main content

Updated Results from the Retrospective CREST Study on the Safety and Effectiveness of 8-Week Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis

  • The CREST Study Group
  • Hannover Medical School
  • Centre for Individualised Infection Medicine (CiiM)
  • Gastroenterologische Gemeinschaftspraxis Herne
  • Goethe University Frankfurt
  • Hospital General Universitario Gregorio Marañon
  • Hospital Universitario de León
  • University of Barcelona
  • Navarra Medical Research Institute
  • Hospital Universitario de Navarra
  • Simon Fraser University
  • Barrie GI Associates
  • University of British Columbia
  • CHU de Clermont-Ferrand
  • Université de Paris
  • Hôpital Saint Eloi
  • Humanitas University
  • IRCCS Istituto Clinico Humanitas - Rozzano (Milano)
  • University of Rome Tor Vergata
  • Catholic University of Sacred Heart
  • IRCCS Fondazione Ca'Granda – Ospedale Maggiore Policlinico - Milano
  • University of Milan
  • University of Salerno
  • University of Modena and Reggio Emilia
  • Western Galilee Medical Center of Nahariya
  • Bar-Ilan University
  • Maccabi Healthcare Services
  • AbbVie

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Updated Results from the Retrospective CREST Study on the Safety and Effectiveness of 8-Week Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases